These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 20110759
41. Treatment of cerebrospinal fluid shunting complications in a Nigerian neurosurgery programme. Case illustrations and review. Komolafe EO, Adeolu AA, Komolafe MA. Pediatr Neurosurg; 2008; 44(1):36-42. PubMed ID: 18097189 [Abstract] [Full Text] [Related]
42. Effect of an intraoperative double-gloving strategy on the incidence of cerebrospinal fluid shunt infection. Tulipan N, Cleves MA. J Neurosurg; 2006 Jan; 104(1 Suppl):5-8. PubMed ID: 16509473 [Abstract] [Full Text] [Related]
43. Antibiotic prophylaxis practices in dentistry: a survey of dentists and physicians. Lauber C, Lalh SS, Grace M, Smith MH, MacDougall K, West P, Compton S. J Can Dent Assoc; 2007 Apr; 73(3):245. PubMed ID: 17439709 [Abstract] [Full Text] [Related]
46. The Role of Antibiotic Prophylaxis in Shunt Surgery. Li G, Pu K, Cao Y, Wang J, Sun Z, Li Q. World Neurosurg; 2017 Dec; 108():548-554. PubMed ID: 28838878 [Abstract] [Full Text] [Related]
47. Current use of prophylactic strategies for postoperative atrial fibrillation: a survey of Canadian cardiac surgeons. Price J, Tee R, Lam BK, Hendry P, Green MS, Rubens FD. Ann Thorac Surg; 2009 Jul; 88(1):106-10. PubMed ID: 19559204 [Abstract] [Full Text] [Related]
49. Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components. Sciubba DM, Lin LM, Woodworth GF, McGirt MJ, Carson B, Jallo GI. Neurosurg Focus; 2007 Apr 15; 22(4):E9. PubMed ID: 17613199 [Abstract] [Full Text] [Related]
50. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period. Conen A, Walti LN, Merlo A, Fluckiger U, Battegay M, Trampuz A. Clin Infect Dis; 2008 Jul 01; 47(1):73-82. PubMed ID: 18484878 [Abstract] [Full Text] [Related]
51. Treatment and prevention of infections of cerebrospinal fluid shunts. Fan-Havard P, Nahata MC. Clin Pharm; 1987 Nov 01; 6(11):866-80. PubMed ID: 3315400 [Abstract] [Full Text] [Related]
52. A reappraisal of contributing factors leading to shunt infection. Khan I, Burhan M, Nadeem M. J Ayub Med Coll Abbottabad; 2009 Nov 01; 21(1):66-8. PubMed ID: 20364744 [Abstract] [Full Text] [Related]
56. Prophylactic antibiotics and evaluation scheme following febrile urinary tract infection in children: a nationwide Israeli survey. Fisch N, Ashkenazi S, Davidovits M. Isr Med Assoc J; 2009 Nov 01; 11(11):677-82. PubMed ID: 20108555 [Abstract] [Full Text] [Related]
57. Infection rates during eras of intrathecal antibiotic use followed by antibiotic-impregnated catheter use in prevention of cerebrospinal fluid shunt infection. Simon TD, Hayati Rezvan P, Coffin SE, Hall M, Hauptman JS, Kronman MP, Mangano FT, Podkovik S, Pollack IF, Schaffzin JK, Thorell E, Warf BC, Zhou C, Whitlock KB. J Neurosurg Pediatr; 2024 Oct 01; 34(4):357-364. PubMed ID: 39029119 [Abstract] [Full Text] [Related]
58. Cerebrospinal fluid eosinophilia in children with ventricular shunts. Fulkerson DH, Boaz JC. J Neurosurg Pediatr; 2008 Apr 01; 1(4):288-95. PubMed ID: 18377304 [Abstract] [Full Text] [Related]